Fonar non-compliance could result in securities delisting

Fonar has received another notice of non-compliance from The Nasdaq Stock Market based upon non-compliance with the minimum stockholders' equity requirement of $2.5 million for continued listing on the market.

As set forth in Nasdaq Marketplace Rule 4310(c)(3), the notice could serve as an additional basis for delisting Fonar’s securities from The Nasdaq Capital Market.

As previously announced, on July 8, the Melville, N.Y.-based company received a notice of non-compliance for failure to satisfy Nasdaq’s proxy solicitation and annual meeting requirements.

Fonar requested and subsequently attended a hearing before a Nasdaq Listing Qualifications panel, presenting its plan to regain compliance with those requirements. On Oct. 8, the company filed a definitive proxy statement for the annual shareholders meeting, which is scheduled for Nov. 17.

The panel has not yet rendered a determination from the hearing.

As provided by the most recent notice, the company said it plans to make a written submission to the panel presenting its plan to regain compliance with the Stockholders' Equity Requirement.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.